000 05732nam a22005895i 4500
001 978-981-97-4402-2
003 DE-He213
005 20250516160137.0
007 cr nn 008mamaa
008 240912s2024 si | s |||| 0|eng d
020 _a9789819744022
_9978-981-97-4402-2
050 4 _aRC321-580
072 7 _aPSAN
_2bicssc
072 7 _aSCI089000
_2bisacsh
072 7 _aPSAN
_2thema
082 0 4 _a612.8
_223
245 1 0 _aRecent Advances and Challenges in the Treatment of Major Depressive Disorder
_h[electronic resource] /
_cedited by Yong-Ku Kim.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXXI, 426 p. 13 illus., 8 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aAdvances in Experimental Medicine and Biology,
_x2214-8019 ;
_v1456
505 0 _aPart I. Molecular Biology-based Treatment for Depression -- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder -- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder -- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD) -- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme? -- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression -- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder -- Part II. Brain Network-based Treatments for Depression -- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder -- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression -- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern -- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie -- Part III. Psychological Intervention based Treatments for Depression -- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings -- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research -- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression -- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression -- Part IV. Digital Psychiatry based Treatments for Depression -- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients -- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics -- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders -- Part V. Personalized Precision Treatments for Depression -- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches -- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression -- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine.
520 _aThis book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners.
541 _fUABC ;
_cPerpetuidad
650 0 _aNeurosciences.
650 0 _aMedicine
_xResearch.
650 0 _aBiology
_xResearch.
650 0 _aPhysiology.
650 0 _aClinical medicine
_xResearch.
650 1 4 _aNeuroscience.
650 2 4 _aBiomedical Research.
650 2 4 _aPhysiology.
650 2 4 _aClinical Research.
700 1 _aKim, Yong-Ku.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819744015
776 0 8 _iPrinted edition:
_z9789819744039
776 0 8 _iPrinted edition:
_z9789819744046
830 0 _aAdvances in Experimental Medicine and Biology,
_x2214-8019 ;
_v1456
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-4402-2
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c276396
_d276395